SCHEMBL852342

SCHEMBL852342

CC(=O)N(O)C(=N)c1ccc(Oc2ccc(NS(=O)(=O)c3ccc4ccccc4c3)c(Oc3ccc(C(=N)N(O)C(C)=O)cc3)n2)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 6/20 0.72
ST14 Q9Y5Y6 5/20 0.72
PRSS1 P07477 3/20 0.72
PRSS2 P07478 3/20 0.72
PRSS3 P35030 3/20 0.72
F2 P00734 3/20 0.72
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
GAA P10253 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
PLA2G7 Q13093 1/20 0.43
PGR P06401 1/20 0.41
PLAU P00749 1/20 0.41
SLC16A3 O15427 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL851552 0.88 ST14 (0.71) F10ST14PRSS1PRSS2PRSS3
SCHEMBL851537 0.86 ST14 (0.72) F10ST14PRSS1PRSS2PRSS3
SCHEMBL851801 0.84 F10 (1.00) F10ST14PRSS1PRSS2PRSS3
SCHEMBL851757 0.84 ST14 (0.81) F10ST14PRSS1PRSS2PRSS3
SCHEMBL851853 0.81 ST14 (0.74) F10ST14PRSS1PRSS2PRSS3
SCHEMBL3798064 0.78 PRSS1 (0.78) F10ST14PRSS1PRSS2PRSS3
SCHEMBL850942 0.76 ST14 (0.68) F10ST14PRSS1PRSS2PRSS3
SCHEMBL8513503 0.73 PRSS1 (0.56) F10ST14PRSS1PRSS2PRSS3
SCHEMBL851794 0.71 F10 (1.00) F10ST14PRSS1PRSS2PRSS3
SCHEMBL850835 0.71 ST14 (0.75) F10ST14PRSS1PRSS2PRSS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140200225-A1 PROTEASE INHIBITORS ORION CORPORATION (FI) 2014-07-17 US disclosed
US-8722930-B2 Protease inhibitors ORION CORPORATION (FI) 2014-05-13 US disclosed
US-20120136002-A1 PROTEASE INHIBITORS AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) 2012-05-31 US disclosed
EP-2432556-A1 PROTEASE INHIBITORS Orion Corporation (FI) 2012-03-28 EP disclosed
WO-2010133748-A1 PROTEASE INHIBITORS ORION CORPORATION (FI) 2010-11-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140200225-A1 PROTEASE INHIBITORS SERPINB1, TMPRSS15, PRSS1 F10 152/4885ST14 216/4885PRSS1 3/4885
US-20120136002-A1 PROTEASE INHIBITORS SERPINB1, TMPRSS15, PRSS1 F10 152/4885ST14 216/4885PRSS1 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.